72,265 Shares in Cardinal Health, Inc. $CAH Bought by Nykredit A S

Nykredit A S purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 72,265 shares of the company’s stock, valued at approximately $17,167,000.

Several other large investors have also made changes to their positions in the company. B. Metzler seel. Sohn & Co. AG increased its holdings in Cardinal Health by 111.8% in the second quarter. B. Metzler seel. Sohn & Co. AG now owns 26,592 shares of the company’s stock worth $6,317,000 after buying an additional 14,039 shares during the last quarter. XML Financial LLC bought a new stake in shares of Cardinal Health during the 2nd quarter worth about $210,000. Laidlaw Wealth Management LLC boosted its position in Cardinal Health by 91.1% during the second quarter. Laidlaw Wealth Management LLC now owns 2,565 shares of the company’s stock worth $609,000 after purchasing an additional 1,223 shares during the period. Symphony Financial Ltd. Co. boosted its holdings in shares of Cardinal Health by 6.3% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 3,624 shares of the company’s stock worth $857,000 after buying an additional 214 shares during the period. Finally, Lone Peak Global Investors LLC boosted its holdings in Cardinal Health by 6.1% during the second quarter. Lone Peak Global Investors LLC now owns 121,090 shares of the company’s stock valued at $28,766,000 after acquiring an additional 6,928 shares during the period. Institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Leerink Partners set a $292.00 target price on shares of Cardinal Health in a research note on Tuesday, August 11th. TD Cowen lifted their target price on Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Citigroup boosted their price target on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Finally, Barclays upped their price target on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, August 13th. Sixteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $266.56.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 80,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the transaction, the chief executive officer owned 235,132 shares of the company’s stock, valued at $55,430,017.68. This represents a 25.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Stephen M. Mason sold 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the transaction, the chief executive officer directly owned 18,061 shares of the company’s stock, valued at $4,269,620.40. This represents a 65.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock valued at $49,626,657 in the last 90 days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Stock Down 0.8%

CAH opened at $246.67 on Friday. The stock has a market cap of $57.37 billion, a P/E ratio of 34.12, a P/E/G ratio of 1.49 and a beta of 0.51. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30. The company has a fifty day simple moving average of $234.23 and a 200 day simple moving average of $219.18.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.